{'fraction_non_alphanumeric': 0.04967197750702906, 'fraction_numerical': 0.020618556701030927, 'mean_word_length': 5.357142857142857, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Extensor tendon entrapment after a Galeazzi-type paediatric fracture

grafting was required, with the tendon of palmaris longus being used to reconstruct the APL tendon and the extensor indicis tendon for the EPB tendon. Steroid injection is the treatment of choice for many clinicians for de Quervain’s disease, on account of its high efficacy and perceived low complication rate (Brinks et al., 2010; Peters-Veluthamaningal et al., 2009). Well recognized local complications of corticosteroid injection for de Quervain’s disease include postinjection pain (13%–18%), subcutaneous fat atrophy (up to 16%), ecchymosis (1%–9%), symptomatic radial nerve lesions (2%) and changes in skin pigmentation (1%) (Brinks et al., 2010). Extensor tendon rupture after steroid injection is rare, but patients should be warned about this, and other, potential complications. Consideration should be given to protecting the tendons with a splint after injections. Furthermore, it is the practice of the senior author (R.E.) to carry out steroid injections under ultrasound guidance.